Table 3

Diagnostic evaluation

AUC
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Correctly classifiedPLR
(95% CI)
NLR
(95% CI)
PPV
(95% CI)
NPV
(95% CI)
Final model0.71
(0.69 to 0.73)
66.0%
(62.2 to 69.7)
66.4%
(65.1 to 67.8)
66.2%1.97
(1.84 to 2.11)
0.51
(0.46 to 0.57)
20.7%
(19.0 to 22.6)
93.6%
(92.8 to 94.4)
Cohort CPR<10th centile0.70
(0.65 to 0.75)
65.9%
(56.9 to 74.1)
65.9%
(62.1 to 69.5)
65.4%1.93
(1.64 to 2.27)
0.52
(0.40 to 0.66)
26.9%
(22.0 to 32.2)
91.0%
(88.1 to 93.4)
Cohort EFW<10th centile0.73
(0.67 to 0.78)
67.6%
(57.9 to 76.3)
68.5%
(63.9 to 72.9)
68.5%2.15
(1.77 to 2.60)
0.47
(0.36 to 0.63)
35.3%
(28.8 to 42.2)
89.3%
(85.4 to 92.4)
Cohort with CPR<10th and EFW<10th centiles0.74
(0.65 to 0.83)
64.4%
(48.8 to 78.1)
65.5%
(56.0 to 74.2)
65.4%1.87
(1.34 to 2.61)
0.54
(0.36 to 0.82)
42.6%
(30.7 to 55.2)
82.2%
(72.7 to 89.5)
Cohort with CPR<10th or EFW<10th centiles0.69
(0.65 to 0.73)
63.5%
(56.2 to 70.4)
63.8%
(60.7 to 66.8)
63.4%1.75
(1.53 to 2.01)
0.57
(0.47 to 0.70)
25.4%
(21.5 to 29.5)
90.0%
(87.5 to 92.1)
  • AUC, area under the curve; NLR, negative likelihood ratio; NPV, negative predictive value; PLR, positive likelihood ratio; PPV, positive predictive value.